-
1
-
-
33846459466
-
Sorting out breast-cancer gene signatures
-
10.1056/NEJMe068292. 17229957
-
Sorting out breast-cancer gene signatures. J Massague, N Engl J Med 2007 356 3 294 297 10.1056/NEJMe068292 17229957
-
(2007)
N Engl J Med
, vol.356
, Issue.3
, pp. 294-297
-
-
Massague, J.1
-
2
-
-
60849097255
-
Gene-expression signatures in breast cancer
-
10.1056/NEJMra0801289. 19228622
-
Gene-expression signatures in breast cancer. C Sotiriou L Pusztai, N Engl J Med 2009 360 8 790 800 10.1056/NEJMra0801289 19228622
-
(2009)
N Engl J Med
, vol.360
, Issue.8
, pp. 790-800
-
-
Sotiriou, C.1
Pusztai, L.2
-
3
-
-
18244409687
-
Gene expression profiling predicts clinical outcome of breast cancer
-
11823860
-
Gene expression profiling predicts clinical outcome of breast cancer. LJ van't Veer H Dai MJ van de Vijver YD He AAM Hart M Mao HL Peterse K van der Kooy MJ Marton AT Witteveen, et al. Nature 2002 415 6871 530 11823860
-
(2002)
Nature
, vol.415
, Issue.6871
, pp. 530
-
-
Van'T Veer, L.J.1
Dai, H.2
Van De Vijver, M.J.3
He, Y.D.4
Hart, A.A.M.5
Mao, M.6
Peterse, H.L.7
Van Der Kooy, K.8
Marton, M.J.9
Witteveen, A.T.10
-
4
-
-
0037137519
-
A gene-expression signature as a predictor of survival in breast cancer
-
DOI 10.1056/NEJMoa021967
-
A gene-expression signature as a predictor of survival in breast cancer. MJ van de Vijver YD He LJ van't Veer H Dai AAM Hart DW Voskuil GJ Schreiber JL Peterse C Roberts MJ Marton, et al. N Engl J Med 2002 347 25 1999 2009 10.1056/NEJMoa021967 12490681 (Pubitemid 35461656)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.25
, pp. 1999-2009
-
-
Van De Vijver, M.J.1
He, Y.D.2
Van 'T Veer, L.J.3
Dai, H.4
Hart, A.A.M.5
Voskuil, D.W.6
Schreiber, G.J.7
Peterse, J.L.8
Roberts, C.9
Marton, M.J.10
Parrish, M.11
Atsma, D.12
Witteveen, A.13
Glas, A.14
Delahaye, L.15
Van Der Velde, T.16
Bartelink, H.17
Rodenhuis, S.18
Rutgers, E.T.19
Friend, S.H.20
Bernards, R.21
more..
-
5
-
-
19944422061
-
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
-
10.1056/NEJMoa041588. 15591335
-
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. S Paik S Shak G Tang C Kim J Baker M Cronin FL Baehner MG Walker D Watson T Park, et al. N Engl J Med 2004 351 27 2817 2826 10.1056/NEJMoa041588 15591335
-
(2004)
N Engl J Med
, vol.351
, Issue.27
, pp. 2817-2826
-
-
Paik, S.1
Shak, S.2
Tang, G.3
Kim, C.4
Baker, J.5
Cronin, M.6
Baehner, F.L.7
Walker, M.G.8
Watson, D.9
Park, T.10
-
6
-
-
33746910265
-
Concordance among Gene-Expression-Based Predictors for Breast Cancer
-
10.1056/NEJMoa052933. 16899776
-
Concordance among Gene-Expression-Based Predictors for Breast Cancer. C Fan DS Oh L Wessels B Weigelt DSA Nuyten AB Nobel LJ van't Veer CM Perou, N Engl J Med 2006 355 6 560 569 10.1056/NEJMoa052933 16899776
-
(2006)
N Engl J Med
, vol.355
, Issue.6
, pp. 560-569
-
-
Fan, C.1
Oh, D.S.2
Wessels, L.3
Weigelt, B.4
Nuyten, D.S.A.5
Nobel, A.B.6
Van'T Veer, L.J.7
Perou, C.M.8
-
7
-
-
51349107911
-
Comparison of prognostic gene expression signatures for breast cancer
-
10.1186/1471-2164-9-394. 18717985
-
Comparison of prognostic gene expression signatures for breast cancer. B Haibe-Kains C Desmedt F Piette M Buyse F Cardoso L van't Veer M Piccart G Bontempi C Sotiriou, BMC Genomics 2008 9 1 394 10.1186/1471-2164-9-394 18717985
-
(2008)
BMC Genomics
, vol.9
, Issue.1
, pp. 394
-
-
Haibe-Kains, B.1
Desmedt, C.2
Piette, F.3
Buyse, M.4
Cardoso, F.5
Van'T Veer, L.6
Piccart, M.7
Bontempi, G.8
Sotiriou, C.9
-
8
-
-
11244258643
-
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis
-
15608639
-
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. A Sweet-Cordero S Mukherjee A Subramanian H You J Roix C Ladd-Acosta J Mesirov T Golub T Jacks, Nat Genet 2005 37 48 55 15608639
-
(2005)
Nat Genet
, vol.37
, pp. 48-55
-
-
Sweet-Cordero, A.1
Mukherjee, S.2
Subramanian, A.3
You, H.4
Roix, J.5
Ladd-Acosta, C.6
Mesirov, J.7
Golub, T.8
Jacks, T.9
-
9
-
-
33645820586
-
Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers
-
10.1200/JCO.2005.03.2755. 16505416
-
Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. DS Oh MA Troester J Usary Z Hu X He C Fan J Wu LA Carey CM Perou, J Clin Oncol 2006 24 11 1656 1664 10.1200/JCO.2005.03.2755 16505416
-
(2006)
J Clin Oncol
, vol.24
, Issue.11
, pp. 1656-1664
-
-
Oh, D.S.1
Troester, M.A.2
Usary, J.3
Hu, Z.4
He, X.5
Fan, C.6
Wu, J.7
Carey, L.A.8
Perou, C.M.9
-
10
-
-
31144459985
-
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
-
10.1038/nature04296. 16273092
-
Oncogenic pathway signatures in human cancers as a guide to targeted therapies. AH Bild G Yao JT Chang Q Wang A Potti D Chasse M-B Joshi D Harpole JM Lancaster A Berchuck, et al. Nature 2006 439 7074 353 10.1038/nature04296 16273092
-
(2006)
Nature
, vol.439
, Issue.7074
, pp. 353
-
-
Bild, A.H.1
Yao, G.2
Chang, J.T.3
Wang, Q.4
Potti, A.5
Chasse, D.6
Joshi, M.-B.7
Harpole, D.8
Lancaster, J.M.9
Berchuck, A.10
-
11
-
-
33846576225
-
Gene expression patterns associated with p53 status in breast cancer
-
10.1186/1471-2407-6-276. 17150101
-
Gene expression patterns associated with p53 status in breast cancer. M Troester J Herschkowitz D Oh X He K Hoadley C Barbier C Perou, BMC Cancer 2006 6 1 276 10.1186/1471-2407-6-276 17150101
-
(2006)
BMC Cancer
, vol.6
, Issue.1
, pp. 276
-
-
Troester, M.1
Herschkowitz, J.2
Oh, D.3
He, X.4
Hoadley, K.5
Barbier, C.6
Perou, C.7
-
12
-
-
33847419142
-
Molecular definition of breast tumor heterogeneity
-
10.1016/j.ccr.2007.01.013. 17349583
-
Molecular definition of breast tumor heterogeneity. M Shipitsin L Campbell P Argani S Weremowicz N Bloushtain-Qimron J Yao T Nikolskaya T Serebryiskaya R Beroukhim M Hu, et al. Cancer Cell 2007 11 259 273 10.1016/j.ccr.2007.01.013 17349583
-
(2007)
Cancer Cell
, vol.11
, pp. 259-273
-
-
Shipitsin, M.1
Campbell, L.2
Argani, P.3
Weremowicz, S.4
Bloushtain-Qimron, N.5
Yao, J.6
Nikolskaya, T.7
Serebryiskaya, T.8
Beroukhim, R.9
Hu, M.10
-
13
-
-
34548863946
-
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
-
10.1186/gb-2007-8-5-r76. 17493263
-
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. JI Herschkowitz K Simin VJ Weigman I Mikaelian J Usary Z Hu KE Rasmussen LP Jones S Assefnia S Chandrasekharan, et al. Genome Biol 2007 8 76 10.1186/gb-2007-8-5-r76 17493263
-
(2007)
Genome Biol
, vol.8
, pp. 1876
-
-
Herschkowitz, J.I.1
Simin, K.2
Weigman, V.J.3
Mikaelian, I.4
Usary, J.5
Hu, Z.6
Rasmussen, K.E.7
Jones, L.P.8
Assefnia, S.9
Chandrasekharan, S.10
-
14
-
-
35248889408
-
EGFR associated expression profiles vary with breast tumor subtype
-
10.1186/1471-2164-8-258. 17663798
-
EGFR associated expression profiles vary with breast tumor subtype. K Hoadley V Weigman C Fan L Sawyer X He M Troester C Sartor T Rieger-House P Bernard L Carey, et al. BMC Genomics 2007 8 1 258 10.1186/1471-2164-8-258 17663798
-
(2007)
BMC Genomics
, vol.8
, Issue.1
, pp. 258
-
-
Hoadley, K.1
Weigman, V.2
Fan, C.3
Sawyer, L.4
He, X.5
Troester, M.6
Sartor, C.7
Rieger-House, T.8
Bernard, P.9
Carey, L.10
-
15
-
-
33847214547
-
The intestinal Wnt/TCF signature
-
10.1053/j.gastro.2006.08.039. 17320548
-
The intestinal Wnt/TCF signature. L Van der Flier J Sabates-Bellver I Oving A Haegebarth M De Palo M Anti M Van Gijn S Suijkerbuijk M Van de Wetering G Marra, et al. Gastroenterology 2007 132 628 632 10.1053/j.gastro.2006.08.039 17320548
-
(2007)
Gastroenterology
, vol.132
, pp. 628-632
-
-
Van Der Flier, L.1
Sabates-Bellver, J.2
Oving, I.3
Haegebarth, A.4
De Palo, M.5
Anti, M.6
Van Gijn, M.7
Suijkerbuijk, S.8
Van De Wetering, M.9
Marra, G.10
-
16
-
-
34250687198
-
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
-
10.1073/pnas.0702507104. 17452630
-
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. LH Saal P Johansson K Holm SK Gruvberger-Saal Q-B She M Maurer S Koujak AA Ferrando P Malmstrm L Memeo, et al. Proc Natl Acad Sci USA 2007 104 18 7564 7569 10.1073/pnas.0702507104 17452630
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, Issue.18
, pp. 7564-7569
-
-
Saal, L.H.1
Johansson, P.2
Holm, K.3
Gruvberger-Saal, S.K.4
She, Q.-B.5
Maurer, M.6
Koujak, S.7
Ferrando, A.A.8
Malmstrm, P.9
Memeo, L.10
-
17
-
-
33845972969
-
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
-
10.1172/JCI28803. 17160137
-
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. E Bosco Y Wang H Xu J Zilfou K Knudsen B Aronow S Lowe K ES, J Clin Invest 2007 117 218 228 10.1172/JCI28803 17160137
-
(2007)
J Clin Invest
, vol.117
, pp. 218-228
-
-
Bosco, E.1
Wang, Y.2
Xu, H.3
Zilfou, J.4
Knudsen, K.5
Aronow, B.6
Lowe, S.7
K, E.S.8
-
18
-
-
59449086167
-
The functional loss of the retinoblastoma tumor suppressor is a common event in Basal-like and Luminal B breast carcinomas
-
(79 September). 10.1186/bcr2142. 18782450
-
The functional loss of the retinoblastoma tumor suppressor is a common event in Basal-like and Luminal B breast carcinomas. J Herschkowitz X He C Fan C Perou, Breast Cancer Research 2008 10 75 (79 September) 10.1186/bcr2142 18782450
-
(2008)
Breast Cancer Research
, vol.10
, pp. 1875
-
-
Herschkowitz, J.1
He, X.2
Fan, C.3
Perou, C.4
-
19
-
-
51649091930
-
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis
-
10.1200/JCO.2007.13.4429. 18757322
-
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. CJ Creighton A Casa Z Lazard S Huang A Tsimelzon SG Hilsenbeck CK Osborne AV Lee, J Clin Oncol 2008 26 25 4078 4085 10.1200/JCO.2007.13.4429 18757322
-
(2008)
J Clin Oncol
, vol.26
, Issue.25
, pp. 4078-4085
-
-
Creighton, C.J.1
Casa, A.2
Lazard, Z.3
Huang, S.4
Tsimelzon, A.5
Hilsenbeck, S.G.6
Osborne, C.K.7
Lee, A.V.8
-
20
-
-
20144374709
-
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients
-
10.1158/0008-5472.CAN-04-3953. 15899795
-
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. H Dai L van't Veer J Lamb YD He M Mao BM Fine R Bernards M van de Vijver P Deutsch A Sachs, et al. Cancer Res 2005 65 10 4059 4066 10.1158/0008-5472.CAN-04-3953 15899795
-
(2005)
Cancer Res
, vol.65
, Issue.10
, pp. 4059-4066
-
-
Dai, H.1
Van'T Veer, L.2
Lamb, J.3
He, Y.D.4
Mao, M.5
Fine, B.M.6
Bernards, R.7
Van De Vijver, M.8
Deutsch, P.9
Sachs, A.10
-
21
-
-
33748286796
-
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
-
10.1038/ng1861. 16921376
-
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. SL Carter AC Eklund IS Kohane LN Harris Z Szallasi, Nat Genet 2006 38 1043 1048 10.1038/ng1861 16921376
-
(2006)
Nat Genet
, vol.38
, pp. 1043-1048
-
-
Carter, S.L.1
Eklund, A.C.2
Kohane, I.S.3
Harris, L.N.4
Szallasi, Z.5
-
22
-
-
37349070024
-
An E2F1-dependent gene expression program that determines the balance between proliferation and cell death
-
10.1016/j.ccr.2007.11.031. 18167332
-
An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. T Hallstrom S Mori J Nevins, Cancer Cell 2008 13 1 2 10.1016/j.ccr.2007.11.031 18167332
-
(2008)
Cancer Cell
, vol.13
, pp. 1-2
-
-
Hallstrom, T.1
Mori, S.2
Nevins, J.3
-
23
-
-
0036841485
-
Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens
-
12414521
-
Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. A Dash IP Maine S Varambally R Shen AM Chinnaiyan MA Rubin, Am J Pathol 2002 161 5 1743 1748 12414521
-
(2002)
Am J Pathol
, vol.161
, Issue.5
, pp. 1743-1748
-
-
Dash, A.1
Maine, I.P.2
Varambally, S.3
Shen, R.4
Chinnaiyan, A.M.5
Rubin, M.A.6
-
24
-
-
33644551073
-
Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers
-
10.1371/journal.pmed.0030047. 16417408
-
Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. J Chi Z Wang D Nuyten E Rodriguez M Schaner A Salim Y Wang G Kristensen A Helland A Børresen-Dale, et al. PLoS Med 2006 3 47 10.1371/journal.pmed.0030047 16417408
-
(2006)
PLoS Med
, vol.3
, pp. 547
-
-
Chi, J.1
Wang, Z.2
Nuyten, D.3
Rodriguez, E.4
Schaner, M.5
Salim, A.6
Wang, Y.7
Kristensen, G.8
Helland, A.9
Børresen-Dale, A.10
-
25
-
-
34248172298
-
Relation of a Hypoxia Metagene Derived from Head and Neck Cancer to Prognosis of Multiple Cancers
-
10.1158/0008-5472.CAN-06-3322. 17409455
-
Relation of a Hypoxia Metagene Derived from Head and Neck Cancer to Prognosis of Multiple Cancers. SC Winter FM Buffa P Silva C Miller HR Valentine H Turley KA Shah GJ Cox RJ Corbridge JJ Homer, et al. Cancer Res 2007 67 7 3441 3449 10.1158/0008-5472.CAN-06-3322 17409455
-
(2007)
Cancer Res
, vol.67
, Issue.7
, pp. 3441-3449
-
-
Winter, S.C.1
Buffa, F.M.2
Silva, P.3
Miller, C.4
Valentine, H.R.5
Turley, H.6
Shah, K.A.7
Cox, G.J.8
Corbridge, R.J.9
Homer, J.J.10
-
26
-
-
65449159747
-
A compact VEGF signature associated with distant metastases and poor outcomes
-
10.1186/1741-7015-7-9. 19291283
-
A compact VEGF signature associated with distant metastases and poor outcomes. Z Hu C Fan C Livasy X He D Oh M Ewend LA Carey S Subramanian R West F Ikpatt, et al. BMC Med 2009 7 9 10.1186/1741-7015-7-9 19291283
-
(2009)
BMC Med
, vol.7
, pp. 9
-
-
Hu, Z.1
Fan, C.2
Livasy, C.3
He, X.4
Oh, D.5
Ewend, M.6
Carey, L.A.7
Subramanian, S.8
West, R.9
Ikpatt, F.10
-
27
-
-
33745259517
-
Cell-type specific gene expression profiles of leukocytes in human peripheral blood
-
10.1186/1471-2164-7-115. 16704732
-
Cell-type specific gene expression profiles of leukocytes in human peripheral blood. C Palmer M Diehn A Alizadeh B PO, BMC Genomics 2006 7 115 10.1186/1471-2164-7-115 16704732
-
(2006)
BMC Genomics
, vol.7
, pp. 115
-
-
Palmer, C.1
Diehn, M.2
Alizadeh, A.3
B, P.O.4
-
28
-
-
34547926839
-
LKB1 modulates lung cancer differentiation and metastasis
-
10.1038/nature06030. 17676035
-
LKB1 modulates lung cancer differentiation and metastasis. H Ji MR Ramsey DN Hayes C Fan K McNamara P Kozlowski C Torrice MC Wu T Shimamura SA Perera, et al. Nature 2007 448 7155 807 10.1038/nature06030 17676035
-
(2007)
Nature
, vol.448
, Issue.7155
, pp. 807
-
-
Ji, H.1
Ramsey, M.R.2
Hayes, D.N.3
Fan, C.4
McNamara, K.5
Kozlowski, P.6
Torrice, C.7
Wu, M.C.8
Shimamura, T.9
Perera, S.A.10
-
29
-
-
41449118521
-
Module map of stem cell genes guides creation of epithelial cancer stem cells
-
10.1016/j.stem.2008.02.009. 18397753
-
Module map of stem cell genes guides creation of epithelial cancer stem cells. D Wong H Liu T Ridky D Cassarino E Segal H Chang, Cell Stem Cell 2008 2 333 344 10.1016/j.stem.2008.02.009 18397753
-
(2008)
Cell Stem Cell
, vol.2
, pp. 333-344
-
-
Wong, D.1
Liu, H.2
Ridky, T.3
Cassarino, D.4
Segal, E.5
Chang, H.6
-
30
-
-
42649112047
-
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
-
10.1038/ng.127. 18443585
-
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. I Ben-Porath M Thomson V Carey R Ge G Bell A Regev R Weinberg, Nat Genet 2008 40 499 507 10.1038/ng.127 18443585
-
(2008)
Nat Genet
, vol.40
, pp. 499-507
-
-
Ben-Porath, I.1
Thomson, M.2
Carey, V.3
Ge, R.4
Bell, G.5
Regev, A.6
Weinberg, R.7
-
31
-
-
34648829133
-
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
-
10.1186/gb-2007-8-8-r157. 17683518
-
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. AE Teschendorff A Miremadi S Pinder I Ellis C Caldas, Genome Biol 2007 8 157 10.1186/gb-2007-8-8-r157 17683518
-
(2007)
Genome Biol
, vol.8
, pp. 18157
-
-
Teschendorff, A.E.1
Miremadi, A.2
Pinder, S.3
Ellis, I.4
Caldas, C.5
-
32
-
-
36348993857
-
High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates
-
10.1158/0008-5472.CAN-07-0539. 18006808
-
High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates. G Alexe GS Dalgin D Scanfeld P Tamayo JP Mesirov C DeLisi L Harris N Barnard M Martel AJ Levine, et al. Cancer Res 2007 67 22 10669 10676 10.1158/0008-5472.CAN-07-0539 18006808
-
(2007)
Cancer Res
, vol.67
, Issue.22
, pp. 10669-10676
-
-
Alexe, G.1
Dalgin, G.S.2
Scanfeld, D.3
Tamayo, P.4
Mesirov, J.P.5
Delisi, C.6
Harris, L.7
Barnard, N.8
Martel, M.9
Levine, A.J.10
-
33
-
-
20144386127
-
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
-
10.1073/pnas.0409462102. 15701700
-
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. HY Chang DSA Nuyten JB Sneddon T Hastie R Tibshirani T Srlie H Dai YD He LJ van't Veer H Bartelink, et al. Proc Natl Acad Sci USA 2005 102 10 3738 3743 10.1073/pnas.0409462102 15701700
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, Issue.10
, pp. 3738-3743
-
-
Chang, H.Y.1
Nuyten, D.S.A.2
Sneddon, J.B.3
Hastie, T.4
Tibshirani, R.5
Srlie, T.6
Dai, H.7
He, Y.D.8
Van'T Veer, L.J.9
Bartelink, H.10
-
34
-
-
22744445394
-
Determination of stromal signatures in breast carcinoma
-
10.1371/journal.pbio.0030187. 15869330
-
Determination of stromal signatures in breast carcinoma. R West D Nuyten S Subramanian T Nielsen C Corless B Rubin K Montgomery S Zhu R Patel T Hernandez-Boussard, et al. PloS Biol 2005 3 187 10.1371/journal.pbio.0030187 15869330
-
(2005)
PloS Biol
, vol.3
, pp. 5187
-
-
West, R.1
Nuyten, D.2
Subramanian, S.3
Nielsen, T.4
Corless, C.5
Rubin, B.6
Montgomery, K.7
Zhu, S.8
Patel, R.9
Hernandez-Boussard, T.10
-
35
-
-
44349174801
-
The fibromatosis signature defines a robust stromal response in breast carcinoma
-
10.1038/labinvest.2008.31. 18414401
-
The fibromatosis signature defines a robust stromal response in breast carcinoma. AH Beck I Espinosa CB Gilks M van de Rijn RB West, Lab Invest 2008 88 6 591 10.1038/labinvest.2008.31 18414401
-
(2008)
Lab Invest
, vol.88
, Issue.6
, pp. 591
-
-
Beck, A.H.1
Espinosa, I.2
Gilks, C.B.3
Van De Rijn, M.4
West, R.B.5
-
36
-
-
43249121177
-
Stromal gene expression predicts clinical outcome in breast cancer
-
10.1038/nm1764. 18438415
-
Stromal gene expression predicts clinical outcome in breast cancer. G Finak N Bertos F Pepin S Sadekova M Souleimanova H Zhao H Chen G Omeroglu S Meterissian A Omeroglu, et al. Nat Med 2008 14 5 518 10.1038/nm1764 18438415
-
(2008)
Nat Med
, vol.14
, Issue.5
, pp. 518
-
-
Finak, G.1
Bertos, N.2
Pepin, F.3
Sadekova, S.4
Souleimanova, M.5
Zhao, H.6
Chen, H.7
Omeroglu, G.8
Meterissian, S.9
Omeroglu, A.10
-
37
-
-
33749030177
-
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
-
10.1200/JCO.2006.05.6861. 16896004
-
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. KR Hess K Anderson WF Symmans V Valero N Ibrahim JA Mejia D Booser RL Theriault AU Buzdar PJ Dempsey, et al. J Clin Oncol 2006 24 26 4236 4244 10.1200/JCO.2006.05.6861 16896004
-
(2006)
J Clin Oncol
, vol.24
, Issue.26
, pp. 4236-4244
-
-
Hess, K.R.1
Anderson, K.2
Symmans, W.F.3
Valero, V.4
Ibrahim, N.5
Mejia, J.A.6
Booser, D.7
Theriault, R.L.8
Buzdar, A.U.9
Dempsey, P.J.10
-
38
-
-
42149155934
-
A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: Prediction of response using molecular profiling
-
10.1038/sj.bjc.6604322. 18382427
-
A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling. PK Julka RT Chacko S Nag R Parshad A Nair DS Oh Z Hu CB Koppiker S Nair R Dawar, et al. Br J Cancer 2008 98 8 1327 10.1038/sj.bjc.6604322 18382427
-
(2008)
Br J Cancer
, vol.98
, Issue.8
, pp. 1327
-
-
Julka, P.K.1
Chacko, R.T.2
Nag, S.3
Parshad, R.4
Nair, A.5
Oh, D.S.6
Hu, Z.7
Koppiker, C.B.8
Nair, S.9
Dawar, R.10
-
39
-
-
33947225176
-
Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: Rationale for patient selection
-
DOI 10.1158/0008-5472.CAN-06-3633
-
Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection. F Huang K Reeves X Han C Fairchild S Platero TW Wong F Lee P Shaw E Clark, Cancer Res 2007 67 5 2226 2238 10.1158/0008-5472.CAN-06-3633 17332353 (Pubitemid 46424242)
-
(2007)
Cancer Research
, vol.67
, Issue.5
, pp. 2226-2238
-
-
Huang, F.1
Reeves, K.2
Han, X.3
Fairchild, C.4
Platero, S.5
Wong, T.W.6
Lee, F.7
Shaw, P.8
Clark, E.9
-
40
-
-
54749118927
-
Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts
-
10.1158/0008-5472.CAN-08-1404. 18794137
-
Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts. CJ Creighton S Massarweh S Huang A Tsimelzon SG Hilsenbeck CK Osborne J Shou L Malorni R Schiff, Cancer Res 2008 68 18 7493 7501 10.1158/0008-5472.CAN-08-1404 18794137
-
(2008)
Cancer Res
, vol.68
, Issue.18
, pp. 7493-7501
-
-
Creighton, C.J.1
Massarweh, S.2
Huang, S.3
Tsimelzon, A.4
Hilsenbeck, S.G.5
Osborne, C.K.6
Shou, J.7
Malorni, L.8
Schiff, R.9
-
41
-
-
58149330982
-
Meta-analysis of gene expression profiles in breast cancer: Toward a unified understanding of breast cancer subtyping and prognosis signatures
-
10.1186/bcr2124. 18662380
-
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. P Wirapati C Sotiriou S Kunkel P Farmer S Pradervand B Haibe-Kains C Desmedt M Ignatiadis T Sengstag F Schutz, et al. Breast Cancer Research 2008 10 4 65 10.1186/bcr2124 18662380
-
(2008)
Breast Cancer Research
, vol.10
, Issue.4
, pp. 1865
-
-
Wirapati, P.1
Sotiriou, C.2
Kunkel, S.3
Farmer, P.4
Pradervand, S.5
Haibe-Kains, B.6
Desmedt, C.7
Ignatiadis, M.8
Sengstag, T.9
Schutz, F.10
-
42
-
-
51349088017
-
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
-
10.1158/1078-0432.CCR-07-4756. 18698033
-
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. C Desmedt B Haibe-Kains P Wirapati M Buyse D Larsimont G Bontempi M Delorenzi M Piccart S C, Clin Cancer Res 2008 14 5158 5165 10.1158/1078-0432.CCR-07-4756 18698033
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5158-5165
-
-
Desmedt, C.1
Haibe-Kains, B.2
Wirapati, P.3
Buyse, M.4
Larsimont, D.5
Bontempi, G.6
Delorenzi, M.7
Piccart, M.8
S, C.9
-
43
-
-
63849148854
-
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer
-
10.1186/bcr2192. 19014521
-
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer. F Reyal M van Vliet N Armstrong H Horlings K de Visser M Kok A Teschendorff S Mook L van't Veer C Caldas, et al. Breast Cancer Research 2008 10 6 93 10.1186/bcr2192 19014521
-
(2008)
Breast Cancer Research
, vol.10
, Issue.6
, pp. 1893
-
-
Reyal, F.1
Van Vliet, M.2
Armstrong, N.3
Horlings, H.4
De Visser, K.5
Kok, M.6
Teschendorff, A.7
Mook, S.8
Van'T Veer, L.9
Caldas, C.10
-
44
-
-
51649110952
-
Prognostic Utility of the 21-Gene Assay in Hormone Receptor-Positive Operable Breast Cancer Compared with Classical Clinicopathologic Features
-
10.1200/JCO.2007.14.4501. 18678838
-
Prognostic Utility of the 21-Gene Assay in Hormone Receptor-Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features. LJ Goldstein R Gray S Badve BH Childs C Yoshizawa S Rowley S Shak FL Baehner PM Ravdin NE Davidson, et al. J Clin Oncol 2008 26 25 4063 4071 10.1200/JCO.2007.14.4501 18678838
-
(2008)
J Clin Oncol
, vol.26
, Issue.25
, pp. 4063-4071
-
-
Goldstein, L.J.1
Gray, R.2
Badve, S.3
Childs, B.H.4
Yoshizawa, C.5
Rowley, S.6
Shak, S.7
Baehner, F.L.8
Ravdin, P.M.9
Davidson, N.E.10
-
45
-
-
49149129916
-
Gene expression-based survival prediction in lung adenocarcinoma: A multi-site, blinded validation study
-
10.1038/nm.1790. 18641660
-
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. K Shedden JMG Taylor SA Enkemann M-S Tsao TJ Yeatman WL Gerald S Eschrich I Jurisica TJ Giordano DE Misek, et al. Nat Med 2008 14 8 822 10.1038/nm.1790 18641660
-
(2008)
Nat Med
, vol.14
, Issue.8
, pp. 822
-
-
Shedden, K.1
Taylor, J.M.G.2
Enkemann, S.A.3
Tsao, M.-S.4
Yeatman, T.J.5
Gerald, W.L.6
Eschrich, S.7
Jurisica, I.8
Giordano, T.J.9
Misek, D.E.10
-
46
-
-
62449131093
-
Supervised risk predictor of breast cancer based on intrinsic subtypes
-
19204204
-
Supervised risk predictor of breast cancer based on intrinsic subtypes. J Parker M Mullins M Cheang S Leung D Voduc T Vickery S Davies C Fauron X He Z Hu, et al. J Clin Oncol 2009 19204204
-
(2009)
J Clin Oncol
-
-
Parker, J.1
Mullins, M.2
Cheang, M.3
Leung, S.4
Voduc, D.5
Vickery, T.6
Davies, S.7
Fauron, C.8
He, X.9
Hu, Z.10
-
47
-
-
13844310310
-
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
-
15721472
-
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Y Wang J Klijn Y Zhang A Sieuwerts M Look F Yang D Talantov M Timmermans M Meijer-van Gelder J Yu, et al. Lancet 2005 365 671 679 15721472
-
(2005)
Lancet
, vol.365
, pp. 671-679
-
-
Wang, Y.1
Klijn, J.2
Zhang, Y.3
Sieuwerts, A.4
Look, M.5
Yang, F.6
Talantov, D.7
Timmermans, M.8
Meijer-Van Gelder, M.9
Yu, J.10
-
48
-
-
44949121510
-
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
-
10.1186/1471-2164-9-239. 18498629
-
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. S Loi B Haibe-Kains C Desmedt P Wirapati F Lallemand A Tutt C Gillet P Ellis K Ryder J Reid, et al. BMC Genomics 2008 9 1 239 10.1186/1471-2164-9-239 18498629
-
(2008)
BMC Genomics
, vol.9
, Issue.1
, pp. 239
-
-
Loi, S.1
Haibe-Kains, B.2
Desmedt, C.3
Wirapati, P.4
Lallemand, F.5
Tutt, A.6
Gillet, C.7
Ellis, P.8
Ryder, K.9
Reid, J.10
-
49
-
-
33751261643
-
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer
-
10.1158/0008-5472.CAN-05-4414. 17079448
-
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. AV Ivshina J George O Senko B Mow TC Putti J Smeds T Lindahl Y Pawitan P Hall H Nordgren, et al. Cancer Res 2006 66 21 10292 10301 10.1158/0008-5472.CAN-05-4414 17079448
-
(2006)
Cancer Res
, vol.66
, Issue.21
, pp. 10292-10301
-
-
Ivshina, A.V.1
George, J.2
Senko, O.3
Mow, B.4
Putti, T.C.5
Smeds, J.6
Lindahl, T.7
Pawitan, Y.8
Hall, P.9
Nordgren, H.10
-
50
-
-
33646874546
-
The molecular portraits of breast tumors are conserved across microarray platforms
-
10.1186/1471-2164-7-96. 16643655
-
The molecular portraits of breast tumors are conserved across microarray platforms. Z Hu F Cheng DS Oh JS Marron X He BF Qaqish C Livasy LA Carey E Reynolds L Dressler, et al. BMC Genomics 2006 7 96 10.1186/1471-2164-7-96 16643655
-
(2006)
BMC Genomics
, vol.7
, pp. 96
-
-
Hu, Z.1
Cheng, F.2
Oh, D.S.3
Marron, J.S.4
He, X.5
Qaqish, B.F.6
Livasy, C.7
Carey, L.A.8
Reynolds, E.9
Dressler, L.10
-
51
-
-
0347090327
-
Adjustment of systematic microarray data biases
-
10.1093/bioinformatics/btg385. 14693816
-
Adjustment of systematic microarray data biases. M Benito J Parker Q Du J Wu D Xiang CM Perou JS Marron, Bioinformatics 2004 20 1 105 114 10.1093/bioinformatics/btg385 14693816
-
(2004)
Bioinformatics
, vol.20
, Issue.1
, pp. 105-114
-
-
Benito, M.1
Parker, J.2
Du, Q.3
Wu, J.4
Xiang, D.5
Perou, C.M.6
Marron, J.S.7
-
52
-
-
33744960226
-
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
-
10.1001/jama.295.21.2492. 16757721
-
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. LA Carey CM Perou CA Livasy LG Dressler D Cowan K Conway G Karaca MA Troester CK Tse S Edmiston, et al. JAMA 2006 295 2492 2502 10.1001/jama.295.21. 2492 16757721
-
(2006)
JAMA
, vol.295
, pp. 2492-2502
-
-
Carey, L.A.1
Perou, C.M.2
Livasy, C.A.3
Dressler, L.G.4
Cowan, D.5
Conway, K.6
Karaca, G.7
Troester, M.A.8
Tse, C.K.9
Edmiston, S.10
-
53
-
-
77954168391
-
Effect of training-sample size and classification difficulty on the accuracy of genomic predictors
-
10.1186/bcr2468. 20064235
-
Effect of training-sample size and classification difficulty on the accuracy of genomic predictors. V Popovici W Chen B Gallas C Hatzis W Shi F Samuelson Y Nikolsky M Tsyganova A Ishkin T Nikolskaya, et al. Breast Cancer Research 12 1 5 10.1186/bcr2468 20064235
-
Breast Cancer Research
, vol.12
, Issue.1
, pp. 185
-
-
Popovici, V.1
Chen, W.2
Gallas, B.3
Hatzis, C.4
Shi, W.5
Samuelson, F.6
Nikolsky, Y.7
Tsyganova, M.8
Ishkin, A.9
Nikolskaya, T.10
-
54
-
-
79551561956
-
Finding significant monochromatic sample-variable blocks in large datasets
-
19091771
-
Finding significant monochromatic sample-variable blocks in large datasets. A Shabalin V Weigman C Perou A Nobel, Bioinformatics 2009 19091771
-
(2009)
Bioinformatics
-
-
Shabalin, A.1
Weigman, V.2
Perou, C.3
Nobel, A.4
-
55
-
-
66249109653
-
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
-
10.1158/0008-5472.CAN-08-3441. 19435916
-
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics. BT Hennessy A-M Gonzalez-Angulo K Stemke-Hale MZ Gilcrease S Krishnamurthy J-S Lee J Fridlyand A Sahin R Agarwal C Joy, et al. Cancer Res 2009 69 10 4116 4124 10.1158/0008-5472.CAN-08-3441 19435916
-
(2009)
Cancer Res
, vol.69
, Issue.10
, pp. 4116-4124
-
-
Hennessy, B.T.1
Gonzalez-Angulo, A.-M.2
Stemke-Hale, K.3
Gilcrease, M.Z.4
Krishnamurthy, S.5
Lee, J.-S.6
Fridlyand, J.7
Sahin, A.8
Agarwal, R.9
Joy, C.10
-
56
-
-
0142254155
-
A transcriptional response to Wnt protein in human embryonic carcinoma cells
-
10.1186/1471-213X-2-8. 12095419
-
A transcriptional response to Wnt protein in human embryonic carcinoma cells. J Willert M Epping J Pollack P Brown R Nusse, BMC Developmental Biology 2002 2 1 8 10.1186/1471-213X-2-8 12095419
-
(2002)
BMC Developmental Biology
, vol.2
, Issue.1
, pp. 8
-
-
Willert, J.1
Epping, M.2
Pollack, J.3
Brown, P.4
Nusse, R.5
-
57
-
-
0037226593
-
A molecular signature of metastasis in primary solid tumors
-
10.1038/ng1060. 12469122
-
A molecular signature of metastasis in primary solid tumors. S Ramaswamy K Ross E Lander T Golub, Nat Genet 2003 33 49 54 10.1038/ng1060 12469122
-
(2003)
Nat Genet
, vol.33
, pp. 49-54
-
-
Ramaswamy, S.1
Ross, K.2
Lander, E.3
Golub, T.4
-
58
-
-
0038488950
-
A multigenic program mediating breast cancer metastasis to bone
-
10.1016/S1535-6108(03)00132-6. 12842083
-
A multigenic program mediating breast cancer metastasis to bone. Y Kang P Siegel W Shu M Drobnjak S Kakonen C Cordán-Cardo T Guise M J, Cancer Cell 2003 3 537 549 10.1016/S1535-6108(03)00132-6 12842083
-
(2003)
Cancer Cell
, vol.3
, pp. 537-549
-
-
Kang, Y.1
Siegel, P.2
Shu, W.3
Drobnjak, M.4
Kakonen, S.5
Cordán-Cardo, C.6
Guise, T.7
M, J.8
-
59
-
-
0042838307
-
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
-
10.1073/pnas.1732912100. 12917485
-
Breast cancer classification and prognosis based on gene expression profiles from a population-based study. C Sotiriou S-Y Neo LM McShane EL Korn PM Long A Jazaeri P Martiat SB Fox AL Harris ET Liu, Proc Natl Acad Sci USA 2003 100 18 10393 10398 10.1073/pnas.1732912100 12917485
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.18
, pp. 10393-10398
-
-
Sotiriou, C.1
Neo, S.-Y.2
McShane, L.M.3
Korn, E.L.4
Long, P.M.5
Jazaeri, A.6
Martiat, P.7
Fox, S.B.8
Harris, A.L.9
Liu, E.T.10
-
60
-
-
20044377912
-
Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling
-
10.1200/JCO.2005.05.145. 15681518
-
Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling. MPHM Jansen JA Foekens IL van Staveren MM Dirkzwager-Kiel K Ritstier MP Look ME Meijer-van Gelder AM Sieuwerts H Portengen LCJ Dorssers, et al. J Clin Oncol 2005 23 4 732 740 10.1200/JCO.2005.05.145 15681518
-
(2005)
J Clin Oncol
, vol.23
, Issue.4
, pp. 732-740
-
-
Mphm, J.1
Foekens, J.A.2
Van Staveren, I.L.3
Dirkzwager-Kiel, M.M.4
Ritstier, K.5
Look, M.P.6
Meijer-Van Gelder, M.E.7
Sieuwerts, A.M.8
Portengen, H.9
Dorssers, L.C.J.10
-
61
-
-
20444457518
-
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
-
10.1172/JCI23412. 15931389
-
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. G Glinsky O Berezovska A Glinskii, J Clin Invest 2005 115 1503 1521 10.1172/JCI23412 15931389
-
(2005)
J Clin Invest
, vol.115
, pp. 1503-1521
-
-
Glinsky, G.1
Berezovska, O.2
Glinskii, A.3
-
62
-
-
33144462268
-
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
-
10.1093/jnci/djj052. 16478745
-
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. C Sotiriou P Wirapati S Loi A Harris S Fox J Smeds H Nordgren P Farmer V Praz B Haibe-Kains, et al. J Natl Cancer Inst 2006 98 4 262 272 10.1093/jnci/djj052 16478745
-
(2006)
J Natl Cancer Inst
, vol.98
, Issue.4
, pp. 262-272
-
-
Sotiriou, C.1
Wirapati, P.2
Loi, S.3
Harris, A.4
Fox, S.5
Smeds, J.6
Nordgren, H.7
Farmer, P.8
Praz, V.9
Haibe-Kains, B.10
-
63
-
-
33747338731
-
Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis
-
10.1200/JCO.2005.05.1458. 16822846
-
Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis. DW Lin IM Coleman S Hawley CY Huang R Dumpit D Gifford P Kezele H Hung BS Knudsen AR Kristal, et al. J Clin Oncol 2006 24 23 3763 3770 10.1200/JCO.2005.05.1458 16822846
-
(2006)
J Clin Oncol
, vol.24
, Issue.23
, pp. 3763-3770
-
-
Lin, D.W.1
Coleman, I.M.2
Hawley, S.3
Huang, C.Y.4
Dumpit, R.5
Gifford, D.6
Kezele, P.7
Hung, H.8
Knudsen, B.S.9
Kristal, A.R.10
-
64
-
-
38849160275
-
Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer
-
10.1186/gb-2007-8-9-r191. 17868458
-
Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer. M Buess D Nuyten T Hastie T Nielsen R Pesich P Brown, Genome Biology 2007 8 9 191 10.1186/gb-2007-8-9- r191 17868458
-
(2007)
Genome Biology
, vol.8
, Issue.9
, pp. 18191
-
-
Buess, M.1
Nuyten, D.2
Hastie, T.3
Nielsen, T.4
Pesich, R.5
Brown, P.6
-
65
-
-
41549119005
-
Transcriptional program induced by Wnt protein in human fibroblasts suggests mechanisms for cell cooperativity in defining tissue microenvironments
-
10.1371/journal.pone.0000945. 17895986
-
Transcriptional program induced by Wnt protein in human fibroblasts suggests mechanisms for cell cooperativity in defining tissue microenvironments. Z Klapholz-Brown GG Walmsley YM Nusse R Nusse PO Brown, PLoS ONE 2007 2 9 945 10.1371/journal.pone.0000945 17895986
-
(2007)
PLoS ONE
, vol.2
, Issue.9
, pp. 5945
-
-
Klapholz-Brown, Z.1
Walmsley, G.G.2
Nusse, Y.M.3
Nusse, R.4
Brown, P.O.5
-
66
-
-
38949202980
-
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
-
10.1002/path.2278. 18044827
-
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. A Bergamaschi E Tagliabue T Sørlie B Naume T Triulzi R Orlandi H Russnes J Nesland R Tammi P Auvinen, et al. The Journal of Pathology 2008 214 3 357 367 10.1002/path.2278 18044827
-
(2008)
The Journal of Pathology
, vol.214
, Issue.3
, pp. 357-367
-
-
Bergamaschi, A.1
Tagliabue, E.2
Sørlie, T.3
Naume, B.4
Triulzi, T.5
Orlandi, R.6
Russnes, H.7
Nesland, J.8
Tammi, R.9
Auvinen, P.10
-
67
-
-
23144461051
-
Genes that mediate breast cancer metastasis to lung
-
10.1038/nature03799. 16049480
-
Genes that mediate breast cancer metastasis to lung. A Minn G Gupta P Siegel P Bos W Shu D Giri A Viale A Oshen W Gerald J Massague, Nature 2005 436 518 524 10.1038/nature03799 16049480
-
(2005)
Nature
, vol.436
, pp. 518-524
-
-
Minn, A.1
Gupta, G.2
Siegel, P.3
Bos, P.4
Shu, W.5
Giri, D.6
Viale, A.7
Oshen, A.8
Gerald, W.9
Massague, J.10
-
68
-
-
33846425793
-
The prognostic role of a gene signature from tumorigenic breast-cancer cells
-
10.1056/NEJMoa063994. 17229949
-
The prognostic role of a gene signature from tumorigenic breast-cancer cells. R Liu X Wang GY Chen P Dalerba A Gurney T Hoey G Sherlock J Lewicki K Shedden MF Clarke, N Engl J Med 2007 356 3 217 226 10.1056/NEJMoa063994 17229949
-
(2007)
N Engl J Med
, vol.356
, Issue.3
, pp. 217-226
-
-
Liu, R.1
Wang, X.2
Chen, G.Y.3
Dalerba, P.4
Gurney, A.5
Hoey, T.6
Sherlock, G.7
Lewicki, J.8
Shedden, K.9
Clarke, M.F.10
-
69
-
-
0031015557
-
The lasso method for variable selection in the Cox model
-
10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3. 9044528
-
The lasso method for variable selection in the Cox model. R Tibshirani, Stat Med 1997 16 385 395 10.1002/(SICI)1097-0258(19970228)16:4<385::AID- SIM380>3.0.CO;2-3 9044528
-
(1997)
Stat Med
, vol.16
, pp. 385-395
-
-
Tibshirani, R.1
-
70
-
-
0021135218
-
Regression modelling strategies for improved prognostic prediction
-
10.1002/sim.4780030207. 6463451
-
Regression modelling strategies for improved prognostic prediction. F Harrell K Lee R Califf D Pryor R Rosati, Stat Med 1984 3 143 152 10.1002/sim.4780030207 6463451
-
(1984)
Stat Med
, vol.3
, pp. 143-152
-
-
Harrell, F.1
Lee, K.2
Califf, R.3
Pryor, D.4
Rosati, R.5
-
72
-
-
33746547467
-
Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay
-
10.1186/bcr1399. 16626501
-
Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. L Perreard C Fan J Quackenbush M Mullins N Gauthier E Nelson M Mone H Hansen S Buys K Rasmussen, et al. Breast Cancer Research 2006 8 2 23 10.1186/bcr1399 16626501
-
(2006)
Breast Cancer Research
, vol.8
, Issue.2
, pp. 1823
-
-
Perreard, L.1
Fan, C.2
Quackenbush, J.3
Mullins, M.4
Gauthier, N.5
Nelson, E.6
Mone, M.7
Hansen, H.8
Buys, S.9
Rasmussen, K.10
-
73
-
-
44849101184
-
The humoral immune system has a key prognostic impact in node-negative breast cancer
-
10.1158/0008-5472.CAN-07-5206. 18593943
-
The humoral immune system has a key prognostic impact in node-negative breast cancer. M Schmidt D Bohm C von Torne E Steiner A Puhl H Pilch H-A Lehr JG Hengstler H Kolbl M Gehrmann, Cancer Res 2008 68 13 5405 5413 10.1158/0008-5472.CAN-07-5206 18593943
-
(2008)
Cancer Res
, vol.68
, Issue.13
, pp. 5405-5413
-
-
Schmidt, M.1
Bohm, D.2
Von Torne, C.3
Steiner, E.4
Puhl, A.5
Pilch, H.6
Lehr, H.-A.7
Hengstler, J.G.8
Kolbl, H.9
Gehrmann, M.10
-
74
-
-
67651193848
-
T-cell metagene predicts a favourable prognosis in estrogen receptor negative and HER2 positive breast cancers
-
10.1186/bcr2234. 19272155
-
T-cell metagene predicts a favourable prognosis in estrogen receptor negative and HER2 positive breast cancers. A Rody U Holtrich L Pusztai C Liedtke R Gaetje E Ruckhaeberle C Solbach L Hanker A Ahr D Metzler, et al. Breast Cancer Res 2009 11 15 10.1186/bcr2234 19272155
-
(2009)
Breast Cancer Res
, vol.11
, pp. 1815
-
-
Rody, A.1
Holtrich, U.2
Pusztai, L.3
Liedtke, C.4
Gaetje, R.5
Ruckhaeberle, E.6
Solbach, C.7
Hanker, L.8
Ahr, A.9
Metzler, D.10
-
75
-
-
73349119689
-
High Risk of Recurrence for Patients with Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2-Positive, Node-Negative Tumors 1 cm or Smaller
-
10.1200/JCO.2009.23.2025. 19884543
-
High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2-Positive, Node-Negative Tumors 1 cm or Smaller. AM Gonzalez-Angulo JK Litton KR Broglio F Meric-Bernstam R Rakkhit F Cardoso F Peintinger EO Hanrahan A Sahin M Guray, et al. J Clin Oncol 2009 27 34 5700 5706 10.1200/JCO.2009.23.2025 19884543
-
(2009)
J Clin Oncol
, vol.27
, Issue.34
, pp. 5700-5706
-
-
Gonzalez-Angulo, A.M.1
Litton, J.K.2
Broglio, K.R.3
Meric-Bernstam, F.4
Rakkhit, R.5
Cardoso, F.6
Peintinger, F.7
Hanrahan, E.O.8
Sahin, A.9
Guray, M.10
|